EC Number   |
Protein Variants |
Reference |
|---|
   3.4.21.90 | CDELTA(101-105) |
core accumulation, no encapsidation specificity |
699899 |
| 3.4.21.90 | CDELTA(101-110) |
no core accumulation, no encapsidation specificity |
699899 |
| 3.4.21.90 | CDELTA(106-110) |
no core accumulation, no encapsidation specificity |
699899 |
| 3.4.21.90 | CDELTA(107-113) |
no core accumulation, no encapsidation specificity |
699899 |
| 3.4.21.90 | CDELTA(91-100) |
no core accumulation, no encapsidation specificity |
699899 |
| 3.4.21.90 | CDELTA(96-100) |
core accumulation, no encapsidation specificity |
699899 |
| 3.4.21.90 | CDELTA(97-106) |
core accumulation, no encapsidation specificity |
699899 |
| 3.4.21.90 | drug development |
alphavirus core protein is a target for antiviral chemotherapy |
695938 |
| 3.4.21.90 | K102A |
stronger binding affinity for encapsidation signal RNA than the wild-type |
699899 |
| 3.4.21.90 | K109A |
stronger binding affinity for encapsidation signal RNA than the wild-type |
699899 |
